Postoperative cognitive dysfunction
Ingrid Rundshagen, Ingrid Rundshagen
Abstract
Background: Older patients in particular are vulnerable to memory disturbances and other types of cognitive impairment after surgical operations. In one study, roughly 12% of patients over age 60 had postoperative cognitive dysfunction (POCD) three months after surgery. This is an important issue in perioperative care as extensive surgery on older patients becomes more common.
Method: Selective review of the literature.
Results: POCD is usually transient. It is diagnosed by comparing pre- and postoperative findings on psychometric tests. Its pathogenesis is multifactorial, with the immune response to surgery probably acting as a trigger. Factors that elevate the risk of POCD include old age, pre-existing cerebral, cardiac, and vascular disease, alcohol abuse, low educational level, and intra- and postoperative complications. The findings of multiple randomized controlled trials indicate that the method of anesthesia does not play a causal role for prolonged cognitive impairment. POCD is associated with poorer recovery and increased utilization of social financial assistance. It is also associated with higher mortality (hazard ratio 1.63, 95% confidence interval 1.11-2.38). Persistent POCD enters into the differential diagnosis of dementia.
Conclusion: POCD can markedly impair postoperative recovery. The findings of pertinent studies performed to date are difficult to generalize because of heterogeneous patient groups and different measuring techniques and study designs. Further investigation is needed to determine which test instruments are best for clinical use and which preventive strategies might lessen the incidence of POCD.
Figures



Source: PubMed
Prossimi studi clinici
-
Wake Forest University Health SciencesNon ancora reclutamento
-
Wake Forest University Health SciencesNon ancora reclutamento
-
West China Second University HospitalNon ancora reclutamentoSonno | Adenocarcinoma gastrico | Adenocarcinoma della giunzione gastroesofagea | Risposta patologica
-
M.D. Anderson Cancer CenterReclutamentoTrapianto di cellule staminali | Gemcitabina | Docetaxel | Carboplatino | Recidiva pediatrica | Studio Osservazionale Prospettico | Melphalan | Refractory GermStati Uniti
-
Washington University School of MedicineCompass TherapeuticsNon ancora reclutamentoCancro colorettale metastatico | Cancro colorettaleStati Uniti
-
AstraZenecaNon ancora reclutamentoDiabete mellito di tipo 2Stati Uniti, Spagna, Danimarca, Ungheria, Cina, Taiwan, Sud Africa, Grecia, Argentina, Giappone, Corea del Sud, Turchia (Türkiye)
-
Arcus Biosciences, Inc.Non ancora reclutamento
-
West China Second University HospitalNon ancora reclutamentoAdenocarcinoma gastrico | Sofferenza emotiva | Adenocarcinoma della giunzione gastroesofagea | Risposta patologica
-
West Virginia UniversityNon ancora reclutamentoSindrome dell'Intestino Irritabile (IBS-C)Stati Uniti
-
Arrowhead PharmaceuticalsNon ancora reclutamentoPartecipanti sani
-
AstraZenecaNon ancora reclutamentoDiabete mellito di tipo 2Stati Uniti, Danimarca, Regno Unito, Ungheria, Brasile, Vietnam, Malaysia, Taiwan, Cina, Germania, Grecia, Polonia, Ucraina, Cechia, Giappone, Porto Rico, Argentina, Corea del Sud
-
Boehringer IngelheimNon ancora reclutamentoObesità | SovrappesoStati Uniti, Australia, Regno Unito, Canada, Cina, Nuova Zelanda, Corea del Sud